← All companies
AlveoliX
In-vitro models inspired by nature Ι Organs-on-Chip
📍 Bern
Stats
- Employees (LinkedIn)
- 12
- Size bucket
- 11-50 employees
- Followers
- 4728
- Founded
- 2019
- Org type
- Public Company
- Country
- CH
- LinkedIn ID
- 27222994
- Slug
- alveolix
Industries
Biotechnology Research
Specialties
ResearchInnovationTechnologyIn-vitro3D Cell CultureOrgan-on-ChipRespiratory diseasesDrug DevelopmentDrug DiscoveryPreclinical ServicesSafetyEfficacyToxicityand Inhalation
About
Our Vision We aim at changing the way drug development research is done today by providing in-vitro models that reproduce the in-vivo environment in an unprecedented way. These in-vitro models, called organ-on-chips, will make it possible to better predict drugs’ responses in humans than standard in-vitro and in-vivo models and as a consequence to importantly reduce animal testing. Our Mission AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at improving preclinical decision-making and thus reducing drug development costs.
Locations (1)
- Freiburgstrasse 3, Bern, 3010, CH